Live News EQUITY FLASH L impact Nov 17, 2026, 09:45 PM UTC Biogen Drug Benefits Increase at Two Years Biogen's anti-tau Alzheimer's drug slowed cognitive decline by 38% at two years. BIIB SquawkNews Desk